Effect of food on the oral bioavailability of didanosine from encapsulated enteric-coated beads

Journal of Clinical Pharmacology

Volumn 42, Issue 4, 2002, Pages 419-427

  Damle, Bharat D ^a   Yan, Jing He ^a   Behr, Douglas ^a   O'Mara, Edward ^a   Nichola, Peter ^a,b   Kaul, Sanjeev ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; YOGHURT;

ANTIVIRAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG FORMULATION; FAT INTAKE; FOOD DRUG INTERACTION; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; MAXIMUM ALLOWABLE CONCENTRATION; MEAL; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; STOMACH ABSORPTION;

ADMINISTRATION, ORAL; ADULT; ANTI-HIV AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CONFIDENCE INTERVALS; CROSS-OVER STUDIES; DIDANOSINE; DIETARY FATS; FASTING; FEMALE; FOOD-DRUG INTERACTIONS; HUMANS; MALE; MICROSPHERES; TABLETS, ENTERIC-COATED;

EID: 85047697366     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912700222011472     Document Type: Article

References (18)

1. Preformulation solubility and kinetic studies of 2′, 3′-dideoxynucleosides: Potential anti-AIDS agents
2. Bioequivalence of two formulations of didanosine (ddI), enteric coated and the chewable tablet, in healthy volunteers and subjects infected with HIV
3. Lack of effect of didanosine encapsulated enteric coated beadlet formulation on the pharmacokinetics of indinavir, ketoconazole, and ciprofloxacin in healthy subjects
4. The influence of food on the absorption and metabolism of drugs: An update
5. Non-compartmental analysis based on statistical moment theory
6. Reproducibility of ambulatory gastric pH recordings in the corpus and antrum: Effect of food, time, and electrode position
7. Evaluation of two enteric coated formulations of didanosine using pharmacokinetics and γ-scintigraphy in healthy male subjects
8. Oral absorption of anti-AIDS nucleoside analogues: 1. Intestinal transport of didanosine in rat and rabbit preparations
9. Decreased and variable systemic availability of zidovudine in patients with AIDS if administered with a meal
10. Effects of standard breakfast on pharmacokinetics of oral zidovudine in patients with AIDS
11. The effect of a protein meal on zidovudine pharmacokinetics in HIV-infected patients
12. Prolonged, but not diminished, zidovudine absorption induced by a high-fat breakfast
13. Pharmacokinetics of 3TC (GR109714X) administered with and without food to HIV-infected patients
14. The effect of food on pharmacokinetics of zalcitabine in HIV-positive patients
15. Effect of food on the bioavailability of stavudine in subjects with human immunodeficiency virus infection
16. Absolute bioavailability, bioequivalence of three oral formulations, and effect of food
17. Anomalous accumulation and decay of 2′, 3′-dideoxyadenosine-5′-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2′, 3′-dideoxyinosine